Riskpilot← Back to searchSign inGet full accessColzyx AB
ABActiveOrg 5590469788LundResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employees
Revenue 2024
SEK 86K
EBITDA margin
-3477.9%
+41% vs 2024
Equity ratio
95.4%
Financial strength
Net profit 2024
SEK -2,9M
+41% vs 2024
| Revenue | SEK 86K | — |
| EBITDA | SEK -3M | +41% |
| Net profit | SEK -2,9M | +41% |
| Total assets | SEK 17,2M | -19% |
| Equity | SEK 16,4M | -15% |
| Employees | 0 | — |
Legal name
Colzyx AB
Org number
5590469788
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
13 januari 2016
Share capital
SEK 128 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolagets verksamhet är användning och utvecklandet av humana proteiner inom sårläkning, för antibiotikaframställning samt för bioaktiva inplantat-produkter samt därmed förenlig verksamhet.
Address
Lund
Email
info@colzyx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1 258 | 725 | 532 | 0 | 0 | 110 | 0 | 86 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | 260 | 119 | −290 | −5 875 | −3 142 | −4 041 | −4 563 | −5 028 | −2 991 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 260 | 119 | −290 | −5 875 | −3 142 | −4 041 | −4 563 | −5 028 | −2 991 |
| Net financials | — | — | — | — | −1 | — | −759 | 118 | 86 |
| Profit before tax | 260 | 119 | −290 | −5 875 | −3 143 | −4 041 | −5 323 | −4 910 | −2 906 |
| Tax | −59 | −27 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 201 | 92 | −290 | −5 875 | −3 143 | −4 041 | −5 323 | −4 910 | −2 906 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 523 | 478 | 4 450 | 9 596 | 12 393 | 39 219 | 30 828 | 21 343 | 17 224 |
| Equity | 251 | 343 | 4 168 | 5 144 | 2 001 | 28 339 | 23 981 | 19 341 | 16 435 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 272 | 134 | 282 | 4 452 | 10 392 | 10 880 | 6 847 | 2 002 | 788 |
| Total debt | 272 | 134 | 282 | 4 452 | 10 392 | 10 880 | 6 847 | 2 002 | 788 |
EBITDA margin
-3477.9%
This company
15.8%
Market median
-22112% vs market
20172024
Equity ratio
95.4%
This company
38.2%
Market median
+150% vs market
20172024
Return on equity
-17.7%
This company
18.4%
Market median
-196% vs market
20172024
Net profit margin
-3379.1%
This company
8.1%
Market median
-41817% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-01-01 – 2017-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PL Auditor Substitute | Auditor Substitute | 2022 | — | — |
ST Chief Auditor | Chief Auditor | 2020 | — | — |
KM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Colzyx AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Lenny Persson | Auditor Substitute | 0 companies |
| Sandra Theresa Meijer | Chief Auditor | 0 companies |
| Karin Margareta Elisabeth Bryder | Chief Executive Officer | 0 companies |
| Emil Fredrik Jon Petterström | Deputy Board Member | 0 companies |
| Ingrid Ida Margareta Atteryd Heiman | Board of Directors | 0 companies |
| Cecilia Ann-Christin Malmborg Hager | Board of Directors | 0 companies |
| Blerta Shuka | Board of Directors | 0 companies |
| Ulf Hans Eskil Söderlind | Chairman | 0 companies |
| Johnna Hafner | Board of Directors | 0 companies |
| Göran Conradson | Board of Directors | 0 companies |
| Mitchell Corey Sanders | Board of Directors | 0 companies |
| Arne Roland Leonard Norberg | Board of Directors | 0 companies |
| Jens Staffan Hansson | Chairman | 0 companies |